1. Butler, A., Hills, J. M., Ireland, S. J., Jordan, C. C., and Tyers, M. B. (1988). Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Brit. J. Pharmacol., 94, 397–412.
2. Cohen, M. L., Bloomguist, W., Gidda, J., and Lacefield, W. (1989). Comparison of the 5-HT3 receptor antagonist properties of ICS 205–930, GR 38032F and zacopride. J. Pharmacol. Exp. Ther., 248, 197–201.
3. Gaddum, J. H., and Picarelli, Z. P. (1957). Two kinds of tryptamine receptor. Br. J. Pharmacol Chemother., 12, 323–8.
4. Jones, B. J., Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J., Oakley, N. R., and Tyers, M. B. (1988). The potential anxiolytic activity of GR 38032F, a 5-HT3-receptor antagonist. Brit. J. Pharmacol., 93, 985–93.
5. Kris, M. G., Gralla, R. J., Clark, R. A. and Tyson, L. B. (1988). Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy. J. Clin. Oncol., 6, 659–62.